Oncologists Accepting Molina Healthcare in Boston, MAPage 2
135 verified oncologists in Boston, Massachusetts accept Molina Healthcare. Profiles cover focus areas including Radiation Oncology, Genitourinary Oncology, and Medical Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School.


Heather Jacene, M.D.
Clinical Director, Nuclear Medicine/PET-CT
Oncology


Mark Preston, M.D.
Associate Professor of Surgery, Harvard Medical School
Oncology


Ann Partridge, MD MPH
Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you
Oncology


Elisabeth Battinelli, M.D.
Associate Professor of Medicine, Harvard Medical School; Chief Resident, Medicine
Oncology


Jeremy Abramson, MD
Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Oncology


Jiping Wang, MD, PHD
Surgical Oncologist, Associate Professor of Surgery, Harvard Medical School
Oncology


Filipa Lynce, M.D.
Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute
Oncology


Ann Silk, M.D.
Director of the Merkel Cell Carcinoma Center of Excellence; Assistant Professor of Medicine, Harvard Medical School
Oncology


Neil Horowitz, MD
Surgical Director, Gynecologic Oncology; Director, Clinical Research in Gynecologic Oncology; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Oncology


George Demetri, MD
Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard
Oncology


David Kozono, M.D., PH.D.
Assistant Professor of Radiation Oncology, Harvard Medical School; Director, Thoracic Radiation Oncology
Oncology


Leif Ellisen, MD PHD
Professor of Medicine, Harvard Medical School; Program Director, Breast Medical Oncology, Mass General Cancer Center
Oncology


Michael Hassett, M.D., M.P.H.
Chief Resident in Internal Medicine at the University of Rochester in Rochester, NY, he went on to complete a fellowship in Medical Oncology at Dana-Farber
Oncology


Nikhil Munshi, MD
Professor of Medicine, Department of Medicine, Harvard Medical School; Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology


Rifaquat Rahman, M.D.
Assistant Professor of Radiation Oncology, Harvard Medical School
Oncology


Jonathan Schoenfeld, MD
Professor of Radiation Oncology at Harvard Medical School, Director of Head and Neck and Melanoma Radiation Oncology at Dana-Farber Brigham Cancer Center,
Oncology


Irene Ghobrial, M.D.
Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School
Oncology


Raymond Mak, M.D.
Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation and Director of Patient Safety/Quality in the Department of Radia; Director of Patient Safety and Quality, Radiation Oncology
Oncology


Ole-Petter Hamnvik, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology


Brian Wolpin, M.D.
Director, Gastrointestinal Cancer Center; Director, Hale Family Center for Pancreatic Cancer Research
Oncology